CD 200BTLA deletions in pediatric precursor Bcell acute

CD 200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTCCLG 58951 protocol by Farzaneh Ghazavi, Emmanuelle Clappier, Tim Lammens, Stefan Suciu, Aurélie Caye, Samira Zegrari, Marleen Bakkus, Nathalie Grardel, Yves Benoit, Yves Bertrand, Odile Minckes, Vitor Costa, Alina Ferster, Françoise Mazingue, Geneviève Plat, Emmanuel Plouvier, Marilyne Poirée, Anne Uyttebroeck, Jutte van der Werfften Bosch, Karima Yakouben, Hetty Helsmoortel, Magali Meul, Nadine Van Roy, Jan Philippé, Frank Speleman, Hélène Cavé, Pieter Van Vlierberghe, and Barbara De Moerloose haematol Volume 100(10): 1311 -1319 October 2, 2015 © 2015 by Ferrata Storti Foundation

Characterization of focal deletions of CD 200/BTLA. Farzaneh Ghazavi et al. Haematologica 2015; 100:

Genomic breakpoints of CD 200/BTLA deletions in BCP-ALL patients. Farzaneh Ghazavi et al. Haematologica

Clinical and biological features of BCP-ALL patients according to CD 200/BTLA deletions status. Farzaneh

Frequency of CD 200/BTLA deletions according to BCP-ALL genetic subtypes and genetic risk groups.

Associations between CD 200/BTLA deletions and outcome of all BCP-ALL patients treated according to the EORTC 58951 trial. Farzaneh Ghazavi et al. Haematologica 2015; 100: 1311 -1319 © 2015 by Ferrata Storti Foundation

An overview of event status and relapse types in BCP-ALL patients. Farzaneh Ghazavi et

Associations between CD 200/BTLA deletions and outcome in the intermediate-prognosis genetic risk group of BCP-ALL patients treated according to the EORTC 58951 trial. Farzaneh Ghazavi et al. Haematologica 2015; 100: 1311 -1319 © 2015 by Ferrata Storti Foundation